Showing results (1631-1640 of 1,682) with videos related to
Sort By:
Pageof 169
Mbio|July 20, 2022
Greater Breadth of Vaccine-Induced Immunity in Females than Males Is Mediated by Increased Antibody Diversity in Germinal Center B CellsRebecca L Ursin, Santosh Dhakal, Hsuan Liu, et al.Pediatrics|October 17, 2012
Clinical utility of chromosomal microarray analysisJay W Ellison, J Britt Ravnan, Jill A Rosenfeld, et al.The Journal of Pharmacology and Experimental Therapeutics|April 27, 2017
LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in MiceDavid R Powell, Melinda G Smith, Deon D Doree, et al.Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Substituted 3-(4-(1,3,5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitorsHaihong Jin, Giovanni Cianchetta, Arokiasamy Devasagayaraj, et al.Immunity|February 11, 2023
Infection induces tissue-resident memory NK cells that safeguard tissue healthIona S Schuster, Xavier Y X Sng, Colleen M Lau, et al.American Journal of Hypertension|October 7, 2017
Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical TrialCarolyn H Still, Carlos J Rodriguez, Jackson T Wright, et al.Acta Crystallographica. Section D, Biological Crystallography|April 5, 2011
Overview of the CCP4 suite and current developmentsMartyn D Winn, Charles C Ballard, Kevin D Cowtan, et al.Science (New York, N.Y.)|October 5, 2002
Malaria control with genetically manipulated insect vectorsLuke Alphey, C Ben Beard, Peter Billingsley, et al.Journal of Medicinal Chemistry|June 19, 2008
Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potential treatment of functional gastrointestinal disordersZhi-Cai Shi, Arokiasamy Devasagayaraj, Kunjian Gu, et al.Genome Biology|March 29, 2023
CRISPR screens identify gene targets at breast cancer risk lociNatasha K Tuano, Jonathan Beesley, Murray Manning, et al.Pageof 169